Syndrome News and Research

RSS
Study finds correlation between neutralizing antibody titer and reported vaccine efficacy

Study finds correlation between neutralizing antibody titer and reported vaccine efficacy

Vaccine-induced SARS-CoV2 immune responses decline at similar rates as those after infection, study finds

Vaccine-induced SARS-CoV2 immune responses decline at similar rates as those after infection, study finds

Universal screening for SARS-CoV-2 among hospitalized patients may be ineffective

Universal screening for SARS-CoV-2 among hospitalized patients may be ineffective

Peripheral nerve injuries and severe COVID-19

Peripheral nerve injuries and severe COVID-19

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

How effective are COVID-19 vaccines against SARS-CoV-2 variants of concern?

How effective are COVID-19 vaccines against SARS-CoV-2 variants of concern?

Greater viral load of SARS-CoV-2 variants of concern increases transmission potential

Greater viral load of SARS-CoV-2 variants of concern increases transmission potential

Human coronavirus replicates in bats without using the spike protein

Human coronavirus replicates in bats without using the spike protein

Researchers model impact of changes in contact rate patterns on COVID-19 incidence in US

Researchers model impact of changes in contact rate patterns on COVID-19 incidence in US

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Study shows Delta variant is main variant causing vaccine breakthrough COVID-19 infections, irrespective of manufacturer

Study shows Delta variant is main variant causing vaccine breakthrough COVID-19 infections, irrespective of manufacturer

Southeast Asia - A hotspot of many viruses with potential to cause pandemics

Southeast Asia - A hotspot of many viruses with potential to cause pandemics

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

A retrospective surveillance study of Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccination in Israel

A retrospective surveillance study of Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccination in Israel

The role of heating, ventilation, and air-conditioning in virus transmission, including SARS-CoV-2

The role of heating, ventilation, and air-conditioning in virus transmission, including SARS-CoV-2

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

NIAID awards approximately $36.3 million to fuel vaccine research for coronaviruses

NIAID awards approximately $36.3 million to fuel vaccine research for coronaviruses

COVID-19 vaccination reduces risk and duration of SARS-CoV-2 infection

COVID-19 vaccination reduces risk and duration of SARS-CoV-2 infection

Caspase-11 identified as regulator of inflammatory pathology in SARS-CoV-2 infections

Caspase-11 identified as regulator of inflammatory pathology in SARS-CoV-2 infections

Scientists create new compliance-based model for SARS-CoV-2 transmission

Scientists create new compliance-based model for SARS-CoV-2 transmission

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.